Post-COVID-19-associated decline in long-term male fertility and embryo quality during assisted reproductive technology

Learning points for clinicians Coronavirus disease 2019 (COVID-19) can impair male fertility with alterations in sperm morphology and DNA integrity could be a major post-COVID-19 complication in men. All the clinicians should suggest periodic andrological assessment for COVID-19 'infected' and 'recovered' patients. Further, all the men for ART should be tested for COVID-19 before the procedure.

Automated summary

COVID-19 can impair male fertility, clinicians should regularly assess patients' reproductive health and men undergoing assisted reproductive technology should be tested for COVID-19 before procedures.